Table 1. Sociodemographic and Clinical Characteristics of Participants Who Completed the PHQ-9 at the Time of Randomizationa.
| Characteristic | Participants, No. (%) | P valueb | |
|---|---|---|---|
| Placebo (n = 607) | Fluoxetine (n = 614) | ||
| Age, y | |||
| <60 | 221 (36.4) | 226 (36.8) | .64 |
| 60-69 | 179 (29.5) | 193 (31.4) | |
| ≥70 | 207 (34.1) | 195 (31.8) | |
| Male | 378 (62.3) | 397 (64.7) | .39 |
| Origin | |||
| Vietnam | 352 (58.0) | 339 (55.2) | .56 |
| Australia | 238 (39.2) | 254 (41.4) | |
| New Zealand | 17 (2.8) | 21 (3.4) | |
| Living alone | 71 (11.7) | 70 (11.4) | .87 |
| NIHSS score | |||
| <5 | 255 (42.0) | 238 (38.8) | .48 |
| 5-15 | 337 (55.5) | 362 (59.0) | |
| >15 | 15 (2.5) | 14 (2.3) | |
| Ischemic strokec | 517 (85.3) | 526 (86.1) | .70 |
| Classification | |||
| Uncertaind | 91 (15.0) | 90 (14.7) | .81 |
| LACS | 103 (17.0) | 114 (18.6) | |
| PACS | 274 (45.1) | 258 (42.0) | |
| POCS | 103 (17.0) | 113 (18.4) | |
| TACS | 36 (5.9) | 39 (6.4) | |
| Depression treatment | |||
| Previous | 18 (3.0) | 30 (4.9) | .08 |
| Current | 16 (2.6) | 15 (2.4) | .83 |
Abbreviations: LACS, lacunar syndrome; NIHSS, National Institutes of Health Stroke Scale; PACS, partial anterior circulation syndrome; PHQ-9, 9-item Patient Health Questionnaire; POCS, posterior circulation syndrome; TACS, total anterior circulation syndrome.
a
A total of 59 participants who did not complete the PHQ-9 at randomization were excluded from all analyses.
b
Derived from analysis of contingency tables using the Pearson χ2 statistic.
c
Information not available for 4 participants (1 in the placebo group and 3 in the fluoxetine group).
d
Includes cases for which this information was missing and cases of hemorrhagic stroke.